Literature DB >> 2428722

Interferon in viral hepatitis: role in pathogenesis and treatment.

G L Davis, J H Hoofnagle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2428722     DOI: 10.1002/hep.1840060537

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  20 in total

1.  The intracellular activation of lamivudine (3TC) and determination of 2'-deoxycytidine-5'-triphosphate (dCTP) pools in the presence and absence of various drugs in HepG2 cells.

Authors:  S Kewn; P G Hoggard; S D Sales; M A Johnson; D J Back
Journal:  Br J Clin Pharmacol       Date:  2000-12       Impact factor: 4.335

2.  Gary L. Davis, MD: a conversation with the editor. Interview by William Clifford Roberts.

Authors:  Gary L Davis
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-01

Review 3.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

4.  In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus.

Authors:  B Lee; W X Luo; S Suzuki; M J Robins; D L Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

Review 5.  Interferon in the management of chronic hepatitis B.

Authors:  R P Perrillo
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

6.  New approach to HCV treatment. Recognition of disease process as systemic viral infection rather than as liver disease.

Authors:  L Friedlander; D H van Thiel; H Faruki; P J Molloy; R J Kania; T Hassanein
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

7.  Low serum levels of alpha-interferon, gamma-interferon, and interleukin-2 in alcoholic cirrhosis.

Authors:  M M Vicente-Gutiérrez; A Diez Ruiz; B Gil Extremera; J M Bermúdez García; F Gutiérrez Gea
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

8.  Glycyrrhizin withdrawal followed by human lymphoblastoid interferon in the treatment of chronic hepatitis B.

Authors:  J Hayashi; W Kajiyama; A Noguchi; K Nakashima; M Hirata; S Hayashi; S Kashiwagi
Journal:  Gastroenterol Jpn       Date:  1991-12

9.  Inhibition of episomal hepatitis B virus DNA in vitro by 2,4-diamino-7- (2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-pyrrolo[2,3-d]pyrimidine.

Authors:  J O Ojwang; B K Bhattacharya; H B Marshall; B E Korba; G R Revankar; R F Rando
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

10.  Effects of antiviral agents on chronic hepatitis B. Analysis using Cox proportional hazard model.

Authors:  S Takano; M Omata; O Yokosuka; F Imazeki; M Ohto
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.